Cyclic benzimidazole derivatives and their antitumor activity;Ciklički derivati benzimidazola i njihovo antitumorsko djelovanje

Kemija u industriji/Journal of Chemists and Chemical Engineers

Volumn 57, Issue 6, 2008, Pages 299-306

  Hranjec, M ^a,b   Karminski Zamola, G ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BIOMOLECULES; CHROMOPHORES; DNA; DNA SEQUENCES; DRUG PRODUCTS; ORGANIC POLYMERS; TRANSCRIPTION;

ANTI-TUMOR ACTIVITIES; BENZIMIDAZOLE DERIVATIVES; BENZIMIDAZOLE GROUPS; DRUG-DNA INTERACTIONS; GENE TRANSCRIPTIONS; HETEROCYCLIC COMPOUND; NATURALLY OCCURRING; STRUCTURAL SIMILARITY;

GENE ENCODING;

EID: 46749087108     PISSN: 00229830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. K. Starčević, M. Kralj, K. Ester, C. Karminski-Zamola, Heterocycles 71 (2007) 647.
2. M. Hranjec, Sinteza, biološko djelovanje i interakcija s ct-DNA novih derivata benzimidazola, Doktorská disertacija, Zagreb, veljača 2007.
3. D. Lednicer, Strategies for Organic Drug Synthesis and Design, John Wiley & Sons, New York, 1998.
4. K. Starčević, D. W. Boykin, G. Karminski-Zamola, Heterocyclic Comm. 8(2002)221.
5. L. Garuti, M. Roberti, C. Cermelli, Bioorg. Med. Chem. Lett. 9 (1999) 2525.
6. S. A. M. El-Hawash, E. Badawey, O. Kappe, Pharmazie 54 (1999) 341.
7. A. R. Katritzky, D. O. Tymoshenko, D. Monteux, V. Vvedensky, G. Nikonov, C. B. Cooper, M. Deshpande, J. Org. Chem. 65 (2000) 8059.
8. S. Demirayak, U. Abu Mobsen, A. Cagri Karaburun, Eur. J. Med. Chem. 37 (2002) 255.
9. M. A. Ismail, R. Brun, T. Wenzler, F. A. Tanious, W. D. Wilson, D. W. Boykin, Bioorg. Med. Chem. 12 (2004) 5405.
10. Y. He, J. Yang, W. Baogen, L Risen, E. E. Swayze, Bioorg. & Med. Chem. Lett. 14 (2004) 1217.
11. M. Hranjec, K. Starčević, B. Zamola, S. Mutak, M. Derek, G. Karminski-Zamola, J. Antibiotics 55 (2002) 308.
12. M. Hranjec, M. Grdiša, K. Pavelić, D. W. Boykin, G. Karminski-Zamola, Il Fármaco 58 (2003) 1319.
13. M. Demeunynck, C. Bailly, W. D. Wilson, In DNA and RNA Binders, Wiley-VCH: Weinheim, 2002.
14. C. Bailly, Curr. Med. Chem. 7 (2000) 39.
15. J. B. Chaires, Current Opinion in Structural Biology 8 (1998) 314.
16. J. B. Chaires, Inc. Biopoly. 44 (1997) 201.
17. M. Demeunyck, C. Bailly, W. D. Wilson, Small Molecule DNA and RNA Binders, John Wiley & Sons, New York, 2002.
18. G. Cooper, W. J. Irwin, J. Chem. Soc. Perkin I (1975) 75.
19. G. Morgan, J. Stewart, J. Chem. Soc. (1938) 1295.
20. a) P. E. Vivas-Mejía, J. L Rodríguez-Cabán, M. Díaz-Velázquez, M. G. Hernández-Pérez, O. Cox, F. A. González, Mol. Cell. Biochem. 177 (1997) 69.;
21. b) A A. Alegria, O. Cox, V. Santiago, M. Colon, Z. Reyes, L Zayas, L A. Rivera, J. A. Dumas, Free Radical Biology & Medicine 15 (1993) 49.
22. a) A. E. Alegria, W. Flores, E. Cordones, L Rivera, P. Sanchez-Cruz, M. Cordero, O. Cox, Toxicology 199 (2004) 87.;
23. b) O. Cox, J. A. Prieto, Magnetic Resonance in Chemistry 27 (1989) 1094.
24. a) O. Cox, H. Jackson, V. A. Vargas, A. Bŕez, J. I. Colón, B. C. Gonzalez, M. de León, J. Med. Chem. 25 (1982) 1378;
25. b) M. M. Muir, O. Cox, L A. Rivera, lnorg. Chim. Acta 191 (1992) 131.
26. P. E. Vivas-Mejía, O. Cox, F. A. Gonzeles, Mol. Cell. Biochem. 178 (1998) 203.
27. C. Venkatesh, G. S. M. Sundaram, H. Ila, H. Junjappa, J. Org. Chem. 71 (2006)1280.
28. a) D. Guenther, US Patent, US 4, 124,589 (1978);
29. b) D. Guenther, US Patent, US 4,219,651 (1980).
30. V. U. Shenoy, S. Sesardi, Dyes & Pigments 11 (1989) 137.
31. B. Bangar Raju, T. S. Varadarajan, Spectroscopy Lett. 23 (1990) 821.
32. M. F. Brańa, J. M. Castellano, G. Keilhaurer, A. Machuca, Y. Martin, C. Redondo, E. Schlick, N. Walker, Anti-Cancer Drug Design 9 (1994) 527.
33. C. Lamazzi, S. Leonce, B. Pfeiffer, P. Renard, G. Guillaumet, C.W. Rees, Bioorg. Med. Chem. Lett. 10 (2000) 2183.
34. S. Frčre, V. Thiéry, C. Bailly, T. Besson, Tetrahedron 59 (2003) 773.
35. M. Soukri, G. Guillaumet, T. Besson, D. Aziane, M. Aadil, E. M. Essassi, M. Akssira, Tet. Lett. 41 (2000) 5857.
36. D. Perron, D. Conlon, P. F. Bousquet, S. P. Robinson, J. Heterocyclic Chem. 34 (1997) 807.
37. R. L. Weinkauf, A. Y. Chen, C. Yu, L. Liu, L. Barrows, E. J. LaVoie, Bioorg. Med. Chem. 2 (1994) 781.
38. M. Alajarín, A. Vidal, F. Tovar, C. Conesa, Tetrahedron Lett. 40 (1999) 6127.
39. Q. Sun, E. J. LaVoie, Heterocycles 43 (1996) 737.
40. L. W. Deady, T. Rodemann, C. J. Finlay, B. C. Baguley, W. A. Denny, Anti-Cancer Drug Design 15 (2000) 339.